تعديل

Affichage des articles dont le libellé est Infection worries prompt EU review of Gilead leukemia drug. Afficher tous les articles
Affichage des articles dont le libellé est Infection worries prompt EU review of Gilead leukemia drug. Afficher tous les articles

vendredi 11 mars 2016

Infection worries prompt EU review of Gilead leukemia drug

LONDON (Reuters) - European regulators have started a review into the safety of Gilead Sciences' leukemia drug Zydelig due to concerns over serious adverse events, including deaths.











http://ift.tt/1pd8cO2

from Reuters: Health News
via animenewspro